A primary object of the present invention is to provide a novel combination therapy that exhibits a notable antitumor effect.As means for achieving the object, an antitumor agent comprising a combination of oxaliplatin, paclitaxel, and a combination drug containing tegafur, gimeracil, and oteracil potassium is provided.